Marino Garcia - 16 Mar 2026 Form 4 Insider Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Adam Veness, as attorney-in-fact for Marino Garcia
Issuer symbol
DNTH
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 17:22:50 UTC
Previous filing
13 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Garcia Marino CEO AND PRESIDENT, Director C/O DIANTHUS THERAPEUTICS, INC., 7 TIMES SQUARE, 43RD FLOOR, NEW YORK /s/ Adam Veness, as attorney-in-fact for Marino Garcia 17 Mar 2026 0001669866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNTH Common Stock Options Exercise +59,700 $6.70* 59,700 16 Mar 2026 Direct
transaction DNTH Common Stock Options Exercise +5,592 +9.4% $17.88* 65,292 16 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Options Exercise -59,700 -100% $0.000000* 41 16 Mar 2026 Common Stock 59,700 $6.70 Direct F1
transaction DNTH Stock Option (Right to Buy) Options Exercise -5,592 -2% $0.000000* 269,408 16 Mar 2026 Common Stock 5,592 $17.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vested in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.